Literature DB >> 25019382

HIF-1α-independent hypoxia-induced rapid PTK6 stabilization is associated with increased motility and invasion.

Isabel M Pires1, Nina Jg Blokland2, Agnieke Wt Broos2, Flore-Anne Poujade3, Joana M Senra2, Suzanne A Eccles4, Paul N Span5, Amanda J Harvey6, Ester M Hammond2.   

Abstract

PTK6/Brk is a non-receptor tyrosine kinase overexpressed in cancer. Here we demonstrate that cytosolic PTK6 is rapidly and robustly induced in response to hypoxic conditions in a HIF-1-independent manner. Furthermore, a proportion of hypoxic PTK6 subsequently re-localized to the cell membrane. We observed that the rapid stabilization of PTK6 is associated with a decrease in PTK6 ubiquitylation and we have identified c-Cbl as a putative PTK6 E3 ligase in normoxia. The consequences of hypoxia-induced PTK6 stabilization and subcellular re-localization to the plasma membrane include increased cell motility and invasion, suggesting PTK6 targeting as a therapeutic approach to reduce hypoxia-regulated metastatic potential. This could have particular significance for breast cancer patients with triple negative disease.

Entities:  

Keywords:  Brk; PTK6; hypoxia; invasion; metastasis; migration; ubiquitylation

Mesh:

Substances:

Year:  2014        PMID: 25019382      PMCID: PMC4130728          DOI: 10.4161/cbt.29822

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  43 in total

1.  Use of the xCELLigence system for real-time analysis of changes in cellular motility and adhesion in physiological conditions.

Authors:  Simon Scrace; Eric O'Neill; Ester M Hammond; Isabel M Pires
Journal:  Methods Mol Biol       Date:  2013

2.  A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis.

Authors:  Amrik J Singh; Rosana D Meyer; Gyulmagomed Navruzbekov; Rajani Shelke; Lei Duan; Hamid Band; Susan E Leeman; Nader Rahimi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

3.  Identification of beta-catenin as a target of the intracellular tyrosine kinase PTK6.

Authors:  Helena L Palka-Hamblin; Jessica J Gierut; Wenjun Bie; Patrick M Brauer; Yu Zheng; John M Asara; Angela L Tyner
Journal:  J Cell Sci       Date:  2009-12-21       Impact factor: 5.285

Review 4.  Brk/PTK6 signaling in normal and cancer cell models.

Authors:  Julie H Ostrander; Andrea R Daniel; Carol A Lange
Journal:  Curr Opin Pharmacol       Date:  2010-09-09       Impact factor: 5.547

Review 5.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

Authors:  J M Brown; A J Giaccia
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

6.  Genome-wide analysis of p53 under hypoxic conditions.

Authors:  Ester M Hammond; Daniel J Mandell; Ali Salim; Adam J Krieg; Thomas M Johnson; Haider A Shirazi; Laura D Attardi; Amato J Giaccia
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

7.  Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes.

Authors:  Monika Kasprzycka; Miroslaw Majewski; Zhi-Jong Wang; Andrzej Ptasznik; Maria Wysocka; Qian Zhang; Michal Marzec; Phyllis Gimotty; Mark R Crompton; Mariusz A Wasik
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  Brk protects breast cancer cells from autophagic cell death induced by loss of anchorage.

Authors:  Amanda J Harvey; Caroline J Pennington; Sarah Porter; Rajpal S Burmi; Dylan R Edwards; William Court; Suzanne A Eccles; Mark R Crompton
Journal:  Am J Pathol       Date:  2009-08-06       Impact factor: 4.307

9.  PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas.

Authors:  M Aubele; G Auer; A K Walch; A Munro; M J Atkinson; H Braselmann; T Fornander; J M S Bartlett
Journal:  Br J Cancer       Date:  2007-02-13       Impact factor: 7.640

10.  Expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer and their clinical and prognostic significance.

Authors:  Chao Zhao; Yan Chen; Weiwei Zhang; Jianrong Zhang; Yulian Xu; Wenjie Li; Sunxiao Chen; Anmei Deng
Journal:  Onco Targets Ther       Date:  2013-03-08       Impact factor: 4.147

View more
  9 in total

Review 1.  Targeting protein tyrosine kinase 6 in cancer.

Authors:  Milica B Gilic; Angela L Tyner
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-09-18       Impact factor: 10.680

2.  Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis.

Authors:  Tarah M Regan Anderson; Shihong Ma; Carlos Perez Kerkvliet; Yan Peng; Taylor M Helle; Raisa I Krutilina; Ganesh V Raj; John A Cidlowski; Julie H Ostrander; Kathryn L Schwertfeger; Tiffany N Seagroves; Carol A Lange
Journal:  Mol Cancer Res       Date:  2018-07-10       Impact factor: 5.852

3.  PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells.

Authors:  Koichi Ito; Sun Hee Park; Igor Katsyv; Weijia Zhang; Carmine De Angelis; Rachel Schiff; Hanna Y Irie
Journal:  NPJ Breast Cancer       Date:  2017-11-17

Review 4.  Putting the BRK on breast cancer: From molecular target to therapeutics.

Authors:  Hui Li Ang; Yi Yuan; Xianning Lai; Tuan Zea Tan; Lingzhi Wang; Benjamin BoJun Huang; Vijay Pandey; Ruby Yun-Ju Huang; Peter E Lobie; Boon Cher Goh; Gautam Sethi; Celestial T Yap; Ching Wan Chan; Soo Chin Lee; Alan Prem Kumar
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

5.  Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.

Authors:  M Peng; S M Ball-Kell; A L Tyner
Journal:  Cell Death Dis       Date:  2015-08-06       Impact factor: 8.469

Review 6.  Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs.

Authors:  Roger M Phillips
Journal:  Cancer Chemother Pharmacol       Date:  2016-01-25       Impact factor: 3.333

7.  Transarterial oily chemoembolization with lidamycin shows potent therapeutic efficacy in VX2 rabbit liver tumor.

Authors:  Genshen Zhong; Jinsong Qi; Shuhua Huo; Huichao Xue; Zhishan Xu; Jinsong Li; Yanjun Zhou; Minna Wu; Liang Li
Journal:  Onco Targets Ther       Date:  2015-10-22       Impact factor: 4.147

8.  WSB-1 regulates the metastatic potential of hormone receptor negative breast cancer.

Authors:  Flore-Anne Poujade; Aarren Mannion; Nicholas Brittain; Andrew Theodosi; Ellie Beeby; Katarzyna B Leszczynska; Ester M Hammond; John Greenman; Christopher Cawthorne; Isabel M Pires
Journal:  Br J Cancer       Date:  2018-03-15       Impact factor: 7.640

9.  Breast Tumour Kinase (Brk/PTK6) Contributes to Breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro.

Authors:  Rajpal S Burmi; Gary M Box; Umar Wazir; Haroon A Hussain; Julie A Davies; William J Court; Suzanne A Eccles; Wen G Jiang; Kefah Mokbel; Amanda J Harvey
Journal:  Genes (Basel)       Date:  2022-02-24       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.